Digital therapeutics: where are we standing and what’s next in the EU and the US?

21 Mar 2024 1230 - 1400 GMT

Read more Read less
A webinar presented by the IBA Healthcare and Life Sciences Law Committee and supported by the International Association of Young Lawyers (AIJA)

This webinar will cover the following topics:

  • what digital therapeutics are and their current and potential market figures;
  • what their peculiarities are when compared to drugs and medical devices under EU law, including classification;
  • the main features of the existing regulation in the US;
  • market access issues and reimbursement by national health services: overview of the most advanced national legislations (advanced financing in the US versus emerging schemes in the EU); and
  • challenges related to the validation and certification process.

* By paying the non-member fee, we welcome you as a delegate member of the IBA for the year in which this conference is held, which entitles you to the following benefits:

  • Password access to certain parts of the IBA website.
  • Receipt of IBA E-news and access to online versions of IBA Global Insight.
  • Pay the member rate

** A reduced rate is offered to IBA Corporate Group Members. Please register online to obtain a 25 per cent discount on the IBA Member fee

Fees

IBA member

Free

Non member

Free

Certificate of Attendance

Certificates of attendance for this webinar are only available to IBA members. IBA members who have attended the live broadcast for more than 30 minutes based on verified sign-in and sign-out times will be sent a certificate to the email address provided at the time of registration. Certificates can only be issued to the name provided at the time of registration. If you have any queries relating to your Certificate of Attendance, please email webinars@int-bar.org

Moderator
Koen T'Syen

Moderator
Van Bael & Bellis, Brussels, Belgium

Confirmed speakers
Cécile Théard-Jallu

Opening Remarks
De Gaulle Fleurance, Paris, France; Co-Chair, Healthcare and Life Sciences Law Committee

Janine Reudt-Demont

Opening Remarks
Niederer Kraft Frey AG, Zürich, Switzerland

Read biography
Elisa Stefanini

Speaker
Portolano Cavallo, Rome, Italy; Technology Law Committee Liaison Officer, Healthcare and Life Sciences Law Committee

Allyson Mullen

Speaker
Hyman, Phelps & McNamara, Washington, District of Columbia, USA

Vincent Vercamer

Speaker
French Ministry of Health and Prevention, Paris, France

Yuri Maricich

Speaker
former CMO of Pear Therapeutics, Boston, Massachusetts, USA

Massimo Beccaria

Speaker
Advice Pharma Group , Milan, Italy

Watch webinar